Idiopathic Parkinson's Disease, Constipation
Conditions
Keywords
Biofeedback, constipation, Parkinson's disease
Brief summary
The aims of the investigators' study are to characterize the nature of constipation in idiopathic Parkinson's disease (IPD) and to evaluate the usefulness of biofeedback therapy in constipated IPD patients.
Detailed description
The medical treatment of idiopathic Parkinson's disease (IPD) alleviates constipation symptoms due to the restoration of autonomic dysfunction. However, additional laxatives are usually needed in these patients. Other suppository treatments included stool softeners, dopamine-receptor agonists, botulinum toxins, and prokinetic medications such as tegaserod. Biofeedback therapy (BFT) has been the gold standard for functional constipation with dyssynergic defecation or rectal hyposensitivity. However, researchers have not tried to evaluate its usefulness in constipated IPD patients up to now. The aims of our study are to characterize the nature of constipation in IPD and to evaluate the usefulness of BFT in constipated IPD patients.
Interventions
OTHERbiofeedback therapy
biofeedback therapy was applied using the surface electromyography (EMG) method with a perianal sensor (Perry, Elan, SRS Medical Systems, Redmond, WA, USA) and biofeedback PC equipment (Orion, Platinum, SRS Medical Systems, Inc., Redmond, WA, USA).
Sponsors
Asan Medical Center
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Idiopathic Parkinson's disease
Exclusion criteria
* Secondary Parkinson's disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effectiveness of biofeedback therapy in Parkinson's disease | usually six sessions per one biofeedback for 3 months |
Secondary
| Measure | Time frame |
|---|---|
| to evaluate the constipation type in Parkinson's disease | 3-6 months |
Countries
South Korea
Outcome results
None listed